Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Ingen Technologies Inc. (IGNT : OTC)
 
 • Company Description   
Ingen Technologies, Inc. develops, markets and distributes medical technologies and products with applications in the respiratory device markets and the medical diagnostics market, as well as markets in emergency response, aviation, military and consumer markets. The Company's products include Oxyview and OxyAlert, which are respiratory products and GasAlert, a commercial consumer product using the same technology as OxyAlert. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters. The company also offers a Secure Balance product, a private-label product that includes a vestibular function testing system and balance therapy system for physicians. Ingen Technologies is based in Yucaipa, California.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $ Daily Weekly Monthly
20 Day Moving Average: shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 1.51
52 Week High: $0.00
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week % %
12 Week % %
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
35193 AVENUE A SUITE C
-
YUCAIPA,CA 92399
USA
ph: 800-259-9622
fax: 909-790-7185
None http://www.ingen-tech.com
 
 • General Corporate Information   
Officers
Scott R. Sand - Chairman; C.E.O. and Director
Christopher A. Wirth - C.O.O. and Director
Thomas J. Neavitt - C.F.O. and Secretary
Yong Sin Khoo - Director
Curt A. Miedema - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 45684G508
SIC: 3990
Fiscal Year
Fiscal Year End: May
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 11.00 (0.00:1)
Beta: 1.51
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: %
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
02/28/22 - -
11/30/21 - -
08/31/21 - -
ROA
02/28/22 - -
11/30/21 - -
08/31/21 - -
Current Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Quick Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Operating Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Net Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Pre-Tax Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Book Value
02/28/22 - -
11/30/21 - -
08/31/21 - -
Inventory Turnover
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Equity
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Capital
02/28/22 - -
11/30/21 - -
08/31/21 - -
 

Powered by Zacks Investment Research ©